New Research Results Spotlight Rare Molecular Subtypes in NSCLC
Although molecularly targeted therapies have transformed the treatment paradigm for NSCLC, the kaleidoscope of genomic alterations that affects subsets of patients is straining the limits of current diagnostic and clinical discovery approaches.
Source: onclive.com